Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0623-2019Class II

Genesys 2 Reagent, REF 01-03-0022 intended to be used with automated high performance liquid chromatography...

Trinity Biotech USA / initiated 2018-11-01 / Terminated

Clark Laboratories, Inc. (dba,Trinity Biotech USA) began a recall of Genesys 2 Reagent, REF 01-03-0022 intended to be used with automated high performance liquid chromatography (HPLC) systems employing ion exchange... on . FDA classified it as Class II and gives the reason as "lack of 510K". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-0623-2019
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Trinity Biotech USA
Product
Genesys 2 Reagent, REF 01-03-0022 intended to be used with automated high performance liquid chromatography (HPLC) systems employing ion exchange chromatography. For in vitro diagnostic use only.
Product code
GKA Abnormal Hemoglobin Quantitation
Reason for recall
lack of 510K
FDA root cause
No Marketing Application
Action
The firm initiated the recall by letter on 11/01/2018. The letter explained the problem and requested the return of the recalled items.
Quantity in commerce
216 units
Distribution
IL, WV, NJ, AZ, MD, UT
Product codes and lots
all serial numbers

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0623-2019
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0620-2019Class IITerminatedVoluntary: Firm initiated
Z-0621-2019Class IITerminatedVoluntary: Firm initiated
Z-0622-2019Class IITerminatedVoluntary: Firm initiated
Z-0623-2019Class IITerminatedVoluntary: Firm initiated
Z-0624-2019Class IITerminatedVoluntary: Firm initiated